{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:42:35Z","timestamp":1792107755783,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41433-026-04524-y","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:06:42Z","timestamp":1780290402000},"page":"1686-1694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Uncovering drug-associated risk signals for neovascular age-related macular degeneration: an integrative pharmacovigilance and proteogenomic study"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9015-0480","authenticated-orcid":false,"given":"Hong","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5689-9989","authenticated-orcid":false,"given":"Jingchao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4185-7732","authenticated-orcid":false,"given":"Taomin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"4524_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jama.2023.26074","volume":"331","author":"M Fleckenstein","year":"2024","unstructured":"Fleckenstein M, Schmitz-Valckenberg S, Chakravarthy U. Age-related macular degeneration: a review. JAMA. 2024;331:147\u201357.","journal-title":"JAMA"},{"key":"4524_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41433-024-03373-x","volume":"39","author":"JD Shirian","year":"2025","unstructured":"Shirian JD, Shukla P, Singh RP. Exploring new horizons in neovascular age-related macular degeneration: novel mechanisms of action and future therapeutic avenues. Eye. 2025;39:40\u20134.","journal-title":"Eye"},{"key":"4524_CR3","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1038\/s41433-024-03327-3","volume":"38","author":"H Sun","year":"2024","unstructured":"Sun H, Li L, Bu F, Xin X, Yan J, Huang T. Two-year efficacy and safety of different anti-vascular endothelial growth factor regimens for neovascular age-related macular degeneration: a network meta-analysis of randomized controlled trials. Eye. 2024;38:3473\u201380.","journal-title":"Eye"},{"key":"4524_CR4","doi-asserted-by":"crossref","unstructured":"Marchesi N, Capierri M, Pascale A, Barbieri A. Different therapeutic approaches for dry and wet AMD. Int J Mol Sci. 2024;25:13053.","DOI":"10.3390\/ijms252313053"},{"key":"4524_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s40264-015-0273-0","volume":"38","author":"YS Modi","year":"2015","unstructured":"Modi YS, Tanchon C, Ehlers JP. Comparative safety and tolerability of anti-VEGF therapy in age-related macular degeneration. Drug Saf. 2015;38:279\u201393.","journal-title":"Drug Saf"},{"key":"4524_CR6","doi-asserted-by":"publisher","first-page":"6174","DOI":"10.3390\/ijms26136174","volume":"26","author":"F Jiang","year":"2025","unstructured":"Jiang F, Ma J, Lei C, Zhang Y, Zhang M. Age-related macular degeneration: cellular and molecular signaling mechanisms. Int J Mol Sci. 2025;26:6174.","journal-title":"Int J Mol Sci"},{"key":"4524_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/jamaophthalmol.2025.1455","volume":"143","author":"R Shor","year":"2025","unstructured":"Shor R, Mihalache A, Noori A, Shor R, Kohly RP, Popovic MM, et al. Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration. JAMA Ophthalmol. 2025;143:587.","journal-title":"JAMA Ophthalmol"},{"key":"4524_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ajo.2016.04.022","volume":"168","author":"Z Mammo","year":"2016","unstructured":"Mammo Z, Guo M, Maberley D, Matsubara J, Etminan M. Oral bisphosphonates and risk of wet age-related macular degeneration. Am J Ophthalmol. 2016;168:62\u20137.","journal-title":"Am J Ophthalmol"},{"key":"4524_CR9","doi-asserted-by":"crossref","unstructured":"Huoshen W, Xiong J, Ma X, Wang H, Cheng P, Chen X, et al. Pharmacovigilance-based identification and mechanistic exploration of periodontitis-related drugs. J Clin Periodontol. 2026;53:117\u201326.","DOI":"10.1111\/jcpe.70040"},{"key":"4524_CR10","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jclinepi.2014.03.012","volume":"67","author":"ME Glickman","year":"2014","unstructured":"Glickman ME, Rao SR, Schultz MR. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol. 2014;67:850\u20137.","journal-title":"J Clin Epidemiol"},{"key":"4524_CR11","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM, Franklin M, Oler E, Wilson A, et al. Drugbank 6.0: the drugbank knowledgebase for 2024. Nucleic Acids Res. 2024;52:D1265\u201375.","journal-title":"Nucleic Acids Res"},{"key":"4524_CR12","doi-asserted-by":"publisher","first-page":"D1328","DOI":"10.1093\/nar\/gkae883","volume":"53","author":"AP Davis","year":"2025","unstructured":"Davis AP, Wiegers TC, Sciaky D, Barkalow F, Strong M, Wyatt B, et al. Comparative toxicogenomics database\u2019s 20th anniversary: update 2025. Nucleic Acids Res. 2025;53:D1328\u201334.","journal-title":"Nucleic Acids Res"},{"key":"4524_CR13","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s12020-024-03933-x","volume":"86","author":"H Sun","year":"2024","unstructured":"Sun H, Li L, Yan J, Huang T. Prioritization of drug targets for thyroid cancer: a multi-omics mendelian randomization study. Endocrine. 2024;86:732\u201343.","journal-title":"Endocrine"},{"key":"4524_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipila TP, Kristiansson K, Donner KM, et al. Finngen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508\u201318.","journal-title":"Nature"},{"key":"4524_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37025-7","volume":"14","author":"M Kuchroo","year":"2023","unstructured":"Kuchroo M, Distasio M, Song E, Calapkulu E, Zhang L, Ige M, et al. Single-cell analysis reveals inflammatory interactions driving macular degeneration. Nat Commun. 2023;14:2589.","journal-title":"Nat Commun"},{"key":"4524_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101353","volume":"5","author":"JB Lin","year":"2024","unstructured":"Lin JB, Santeford A, Colasanti JJ, Lee Y, Shah AV, Wang TJ, et al. Targeting cell-type-specific, choroid-peripheral immune signaling to treat age-related macular degeneration. Cell Rep Med. 2024;5:101353.","journal-title":"Cell Rep Med"},{"key":"4524_CR17","doi-asserted-by":"publisher","first-page":"12549","DOI":"10.3390\/ijms232012549","volume":"23","author":"NJY Yeo","year":"2022","unstructured":"Yeo NJY, Wazny V, Nguyen NLU, Ng C, Wu KX, Fan Q, et al. Single-cell transcriptome of wet and patient-derived endothelial cells in angiogenic sprouting. Int J Mol Sci. 2022;23:12549.","journal-title":"Int J Mol Sci"},{"key":"4524_CR18","doi-asserted-by":"publisher","first-page":"D730","DOI":"10.1093\/nar\/gkae1113","volume":"53","author":"D Szklarczyk","year":"2025","unstructured":"Szklarczyk D, Nastou K, Koutrouli M, Kirsch R, Mehryary F, Hachilif R, et al. The string database in 2025: protein networks with directionality of regulation. Nucleic Acids Res. 2025;53:D730\u20137.","journal-title":"Nucleic Acids Res"},{"key":"4524_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.seizure.2020.10.018","volume":"83","author":"A Beydoun","year":"2020","unstructured":"Beydoun A, Dupont S, Zhou D, Matta M, Nagire V, Lagae L. Current role of carbamazepine and oxcarbazepine in the management of epilepsy. Seizure. 2020;83:251\u201363.","journal-title":"Seizure"},{"key":"4524_CR20","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/ehjcvp\/pvab057","volume":"8","author":"R Alcalai","year":"2022","unstructured":"Alcalai R, Butnaru A, Moravsky G, Yagel O, Rashad R, Ibrahimli M, et al. Apixaban vs. Warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial. Eur Heart J Cardiovasc Pharmacother. 2022;8:660\u20137.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"4524_CR21","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s40264-019-00842-1","volume":"42","author":"A Douros","year":"2019","unstructured":"Douros A, Durand M, Doyle C, Yoon S, Reynier P, Filion K. Comparative effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis of observational studies. Drug Saf. 2019;42:1135\u201348.","journal-title":"Drug Saf"},{"key":"4524_CR22","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.3390\/ijms25084346","volume":"25","author":"C Feier","year":"2024","unstructured":"Feier C, Vonica R, Faur A, Streinu D, Muntean C. Assessment of thyroid carcinogenic risk and safety profile of GLP1-ra semaglutide (Ozempic) therapy for diabetes mellitus and obesity: a systematic literature review. Int J Mol Sci. 2024;25:4346.","journal-title":"Int J Mol Sci"},{"key":"4524_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1024068","volume":"13","author":"JM Hartinger","year":"2022","unstructured":"Hartinger JM, Kratky V, Hruskova Z, Slanar O, Tesar V. Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives. Front Immunol. 2022;13:1024068.","journal-title":"Front Immunol"},{"key":"4524_CR24","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1080\/14740338.2023.2252341","volume":"23","author":"S Kandarakis","year":"2024","unstructured":"Kandarakis S, Papadopoulos AP, Roussopoulos G, Georgopoulos E, Chung Y, Doumazos L, et al. COMfort eye trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative-free formulation of latanoprost versus a reference drug (Xalatan\u00ae) in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT). Expert Opin Drug Saf. 2024;23:743\u201354.","journal-title":"Expert Opin Drug Saf"},{"key":"4524_CR25","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1002\/humu.24430","volume":"43","author":"N B\u00f6gershausen","year":"2022","unstructured":"B\u00f6gershausen N, Krawczyk HE, Jamra RA, Lin SJ, Yigit G, H\u00fcning I, et al. WARS1 and SARS1: two tRNA synthetases implicated in autosomal recessive microcephaly. Hum Mutat. 2022;43:1454\u201371.","journal-title":"Hum Mutat"},{"key":"4524_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s44321-023-00004-y","volume":"16","author":"YT Kim","year":"2024","unstructured":"Kim YT, Huh JW, Choi YH, Yoon HK, Nguyen TT, Chun E, et al. Highly secreted tryptophanyl tRNA synthetase 1 as a potential theranostic target for hypercytokinemic severe sepsis. EMBO Mol Med. 2024;16:40\u201363.","journal-title":"EMBO Mol Med"},{"key":"4524_CR27","doi-asserted-by":"crossref","unstructured":"Lee H, Lee E, Uddin MB, Kim T, Kim J, Chathuranga K, et al. Released tryptophanyl-tRNA synthetase stimulates innate immune responses against viral infection. J Virol. 2019;93:e01291\u201318.","DOI":"10.1128\/JVI.01291-18"},{"key":"4524_CR28","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/biom10091283","volume":"10","author":"TTT Nguyen","year":"2020","unstructured":"Nguyen TTT, Yoon HK, Kim YT, Choi YH, Lee W, Jin M. Tryptophanyl-trna synthetase 1 signals activate TREM-1 via TLR2 and TLR4. Biomolecules. 2020;10:1283.","journal-title":"Biomolecules"},{"key":"4524_CR29","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.7150\/ijbs.49890","volume":"16","author":"W Tan","year":"2020","unstructured":"Tan W, Zou J, Yoshida S, Jiang B, Zhou Y. The role of inflammation in age-related macular degeneration. Int J Biol Sci. 2020;16:2989\u20133001.","journal-title":"Int J Biol Sci"},{"key":"4524_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf0555","volume":"16","author":"AS Patel","year":"2024","unstructured":"Patel AS, Ludwinski FE, Kerr A, Farkas S, Kapoor P, Bertolaccini L, et al. A subpopulation of tissue remodeling monocytes stimulates revascularization of the ischemic limb. Sci Transl Med. 2024;16:eadf555.","journal-title":"Sci Transl Med"},{"key":"4524_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02610-0","volume":"9","author":"A Sidibe","year":"2018","unstructured":"Sidibe A, Ropraz P, Jemelin S, Emre Y, Poittevin M, Pocard M, et al. Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours. Nat Commun. 2018;9:355.","journal-title":"Nat Commun"},{"key":"4524_CR32","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","volume":"116","author":"L Ziegler-Heitbrock","year":"2010","unstructured":"Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116:e74\u201380.","journal-title":"Blood"},{"key":"4524_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2025-002339","volume":"11","author":"DF Romdhoniyyah","year":"2026","unstructured":"Romdhoniyyah DF, Alshukri A, Parry DG, Harding S, Beare NAV. Metformin and incidence of age-related macular degeneration in people with diabetes: a population-based 5-year case-control study. BMJ Open Ophthalmol. 2026;11:e2339.","journal-title":"BMJ Open Ophthalmol"},{"key":"4524_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3928\/23258160-20251110-01","volume":"57","author":"C Maatouk","year":"2026","unstructured":"Maatouk C, Hyman M, Shah A, Smith S, Yehia M, Moir J, et al. Association between metformin and other diabetic medications and five-year onset of new neovascular age-related macular degeneration diagnosis. Ophthalmic Surg Lasers Imaging Retin. 2026;57:102\u201311.","journal-title":"Ophthalmic Surg Lasers Imaging Retin"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04524-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04524-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04524-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:09:58Z","timestamp":1785517798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04524-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4524"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04524-y","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}